Haritha Potluri MD in North Brunswick, New Jersey

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 1998
The Primary Medical Specialty for Haritha Potluri MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 27
PAC (PECOS ID)#: 4587665328
NPI #: 1225074701
NPI Created On: 06/21/2006
NPI Last Updated Listed as: 08/22/2012
Primary Taxonomy Code: 207R00000X
License Number:
25MA08083800
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• AmeriHealth New Jersey
• Blue Cross Blue Shield
• AmeriHealth HMO, Inc.
• Humana
• Oscar Garden State Insurance Corporation
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Hindi, Hindi,Tamil,Telugu, English, Telugu, Tamil.

Services and Procedures include:

1. Measurement and graphic recording of total and timed exhaled air capacity
2. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
3. Test for exercise-induced lung stress
4. Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen
5. Determination of lung volumes using plethysmography
6. Measurement of lung diffusing capacity
7. Injection of allergenic extracts into skin, accessed through the skin
8. Measurement of inhaled nitric oxide gas
9. New patient office or other outpatient visit, typically 60 minutes
10. Established patient office or other outpatient, visit typically 25 minutes
11. Established patient office or other outpatient, visit typically 40 minutes
12. Initial hospital inpatient care, typically 70 minutes per day
13. Subsequent hospital inpatient care, typically 35 minutes per day
14. Critical care delivery critically ill or injured patient, first 30-74 minutes
15. Physician telephone patient service, 21-30 minutes of medical discussion
16. Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg